Robert Tressler
Keine laufenden Positionen mehr
Karriereverlauf von Robert Tressler
Ehemalige bekannte Positionen von Robert Tressler
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CHIRON Biopharmaceuticals | Corporate Officer/Principal | - | - |
| LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - | - |
| Syntex, Inc. | Corporate Officer/Principal | - | - |
| Matrix Pharmaceuticals, Inc. | Corporate Officer/Principal | - | - |
| GERON CORPORATION | Corporate Officer/Principal | - | - |
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Technik-/Wissenschafts-/F&E-Leiter | 17.02.2011 | - |
Ausbildung von Robert Tressler
| McNeese State University | Graduate Degree |
| The University of Texas at Austin | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
| Kanada | 2 |
Operativ
| Corporate Officer/Principal | 5 |
| Chief Tech/Sci/R&D Officer | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GERON CORPORATION | Health Technology |
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Health Technology |
| Matrix Pharmaceuticals, Inc. | |
| Syntex, Inc. | Miscellaneous |
| CHIRON Biopharmaceuticals |
- Börse
- Insiders
- Robert Tressler
- Erfahrung
